3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Soft Tissue Sarcomas: new trials by email Literature Review of Soft Tissue Sarcomas trials Research Report on Soft Tissue Sarcomas
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Axitinib, Pembrolizumab - Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas | Phase 2 | Completed | Jonathan Trent, MD, PhD | 33 | 2016-04-19 | 2024-07-12 |
| RAD001 in Advanced Sarcoma RAD001 - Soft Tissue Sarcomas, Bone Sarcomas | Phase 2 | Completed | Asan Medical Center | 41 | 2010-04-01 | 2013-04-12 |
| The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). AZD2171 - Gastrointestinal Stromal Tumors, Soft Tissue Sarcomas | Phase 2 | Completed | AstraZeneca | 35 | 2006-09-01 | 2012-07-16 |
Sarcoma (3) · Bone Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Neoplasms (1) · Sarcoma, Alveolar Soft Part (1)
Neoplasms by Histologic Type (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms (2) · Bone Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Musculoskeletal Diseases (1) · Neoplasms by Site (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Muscle Tissue (1)
Axitinib (1) · Everolimus (1) · cediranib (1) · pembrolizumab (1)
Asan Medical Center (1) · AstraZeneca (1) · Jonathan Trent, MD, PhD (1)
South Korea (1) · United Kingdom (1) · United States (1)
Jane Robertson, MD (1) · Jin-Hee Ahn, MD, PhD (1) · Jonathan C Trent, MD (1)